nach oben

Clinical Rheumatology

Erschienen in:

29.11.2018 | Original Article

Association between hyperuricemia and nontraditional adiposity indices

verfasst von: Xing Zhen Liu, Hui Hua Li, Shan Huang, Dong Bao Zhao

Erschienen in: Clinical Rheumatology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The association between several novel adiposity indices and hyperuricemia is inconclusive. Therefore, we aimed to investigate this association so as to provide theoretical support for the management of hyperuricemia in overweight/obese individuals.

Methods

A cross-sectional study was carried out among 174,698 adults. The values of body adiposity index (BAI), conicity index (CI), a body shape index (ABSI), body roundness index (BRI), visceral adiposity index (VAI), lipid accumulation product (LAP) index, and cardiometabolic index (CMI) were divided into four quartiles, and multivariate logistic analysis was used to analyze the association between them and hyperuricemia. Receiver operating characteristic curve and area under curve (AUC) were used to evaluate the power of predictions for hyperuricemia.

Results

After adjusting for confounding variables, LAP and CMI exhibited stronger association with hyperuricemia than other indices. The odd ratio (OR) for hyperuricemia in the highest quartile of the LAP and CMI was 2.049 (CI 95% = 1.824–2.302) and 4.332(CI 95% = 3.938–4.765). The AUC value of LAP was 0.632 (95% CI = 0.626–0.637), p < 0.001; and the AUC value of CMI was 0.687 (95% CI = 0.682–0.692), p < 0.001. The optimal cutoff values of LAP and CMI were 26.21 and 0.485, respectively.

Conclusions

LAP and CMI, combination of WC and lipid parameters and reliable visceral adiposity indices, were strongly associated with hyperuricemia than other indices. So they could be potential monitoring indicators for hyperuricemia management in overweight/obese individuals.

Kawada T (2018) Hyperuricaemia and type 2 diabetes mellitus. Clin Exp Pharmacol Physiol 45(8):870PubMedCrossRef

von Lueder TG, Girerd N, Atar D, Agewall S, Lamiral Z, Kanbay M et al (2015) High-risk myocardial infarction database initiative investigators. Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the high-risk myocardial infarction database initiative. Eur J Heart Fail 17(11):1144–1151CrossRef

Peng TC, Wang CC, Kao TW, Chan JY, Yang YH, Chang YW et al (2015) Relationship between hyperuricemia and lipid profiles in US adults. Biomed Res Int 2015:127596PubMedPubMedCentral

Qaseem A, Harris RP, Forciea MA, Clinical Guidelines Committee of the American College of Physicians (2017) Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med 166(1):58–68PubMedCrossRef

Hamburger M, Baraf HS, Adamson TC, Basile J, Bass L, Cole B et al (2011) 2011 recommendations for the diagnosis and management of gout and hyperuricemia. Phys Sportsmed 39(4):98–123PubMedCrossRef

Nevill AM, Stewart AD, Olds T, Holder R (2006) Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol 129(1):151–156PubMedCrossRef

Bray GA, Smith SR, de Jonge L, Xie H, Rood J, Martin CK et al (2012) Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. JAMA 307(1):47–55PubMedPubMedCentralCrossRef

Gu Z, Li D, He H, Wang J, Hu X, Zhang P et al (2018) Body mass index, waist circumference, and waist-to-height ratio for prediction of multiple metabolic risk factors in Chinese elderly population. Sci Rep 8(1):385PubMedPubMedCentralCrossRef

Yamada A, Sato KK, Kinuhata S, Uehara S, Endo G, Hikita Y et al (2016) Association of visceral fat and liver fat with hyperuricemia. Arthritis Care Res (Hoboken) 68(4):553–561CrossRef

10.

Wang H, Sun Y, Wang S, Qian H, Jia P, Chen Y et al (2018 May 16) Body adiposity index, lipid accumulation product, and cardiometabolic index reveal the contribution of adiposity phenotypes in the risk of hyperuricemia among Chinese rural population. Clin Rheumatol. https://doi.org/10.1007/s10067-018-4143-x.

11.

Gu D, Ding Y, Zhao Y, Miao S, Qu Q (2018) Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome. Lipids Health Dis 17(1):101PubMedPubMedCentralCrossRef

12.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMedPubMedCentralCrossRef

13.

Ting K, Gill TK, Keen H, Tucker GR, Hill CL (2016) Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study. Intern Med J 46(5):566–573PubMedCrossRef

14.

Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 63(10):3136–3141PubMedCrossRef

15.

Kumar AU, Browne LD, Li X, Adeeb F, Perez-Ruiz F, Fraser AD et al (2018) Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: a cohort study. PLoS One 13(5):e0198197CrossRef

16.

Lai SW, Tan CK, Ng KC (2000) Epidemiology of hyperglycemia in elderly persons. J Gerontol A Biol Sci Med Sci 55(5):M257–M259PubMedCrossRef

17.

Liu H, Zhang XM, Wang YL, Liu BC (2014) Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling. J Nephrol 27(6):653–658PubMedCrossRef

18.

Yang X, Xiao Y, Liu K, Jiao X, Lin X, Wang Y et al (2018) Prevalence of hyperuricemia among the Chinese population of the southeast coastal region and association with single nucleotide polymorphisms in urate-anion exchanger genes: SLC22A12, ABCG2 and SLC2A9. Mol Med Rep 18(3):3050–3058PubMed

19.

Chen JH, Pan WH, Hsu CC, Yeh WT, Chuang SY, Chen PY et al (2013) Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: a prospective study. Arthritis Care Res (Hoboken). 65(1):133–140PubMedCrossRef

20.

You L, Liu A, Wuyun G, Wu H, Wang P (2014) Prevalence of hyperuricemia and the relationship between serum uric acid and metabolic syndrome in the Asian Mongolian area. J Atheroscler Thromb 21(4):355–365PubMedCrossRef

21.

Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG et al (2011) A better index of body adiposity. Obesity (Silver Spring) 19(5):1083–1089PubMedCentralCrossRef

22.

Marcadenti A, Fuchs FD, Moreira LB, Gus M, Fuchs SC (2017) Adiposity phenotypes are associated with type-2 diabetes: LAP index, body adiposity index, and neck circumference. Atherosclerosis 266:145–150PubMedCrossRef

23.

Rost S, Freuer D, Peters A, Thorand B, Holle R, Linseisen J et al (2018) New indexes of body fat distribution and sex-specific risk of total and cause-specific mortality: a prospective cohort study. BMC Public Health 18(1):427PubMedPubMedCentralCrossRef

24.

Bowman K, Atkins JL, Delgado J, Kos K, Kuchel GA, Ble A et al (2017) Central adiposity and the overweight risk paradox in aging: follow-up of 130,473 UK Biobank participants. Am J Clin Nutr 106(1):130–135PubMedPubMedCentralCrossRef

25.

Zhang J, Fang L, Qiu L, Huang L, Zhu W, Yu Y (2017) Comparison of the ability to identify arterial stiffness between two new anthropometric indices and classical obesity indices in Chinese adults. Atherosclerosis 263:263–271PubMedCrossRef

26.

Chen X, Liu Y, Sun X, Yin Z, Li H, Deng K et al (2018) Comparison of body mass index, waist circumference, conicity index, and waist-to-height ratio for predicting incidence of hypertension: the rural Chinese cohort study. J Hum Hypertens 32(3):228–235PubMedCrossRef

27.

Kim TH, Lee SS, Yoo JH, Kim SR, Yoo SJ, Song HC et al (2012) The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr 4(1):3PubMedPubMedCentralCrossRef

28.

Britton KA, Fox CS (2011) Ectopic fat depots and cardiovascular disease. Circulation 124(24):e837–e841PubMedCrossRef

29.

Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K (1997) Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 46(10):1162–1165PubMedCrossRef

30.

Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T (2007) Relationship between hyperuricemia and body fat distribution. Intern Med 46(17):1353–1358PubMedCrossRef

31.

Janghorbani M, Aminorroaya A, Amini M (2017) Comparison of different obesity indices for predicting incident hypertension. High Blood Press Cardiovasc Prev 24(2):157–166PubMedCrossRef

32.

Wakabayashi I, Daimon T (2015) The “cardiometabolic index” as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clin Chim Acta 438:274–278PubMedCrossRef

33.

Krajcoviechova A, Tremblay J, Wohlfahrt P, Bruthans J, Tahir MR, Hamet P et al (2016) The impact of blood pressure and visceral adiposity on the association of serum uric acid with albuminuria in adults without full metabolic syndrome. Am J Hypertens 29(12):1335–1342PubMed

34.

Dong H, Xu Y, Zhang X, Tian S (2017) Visceral adiposity index is strongly associated with hyperuricemia independently of metabolic health and obesity phenotypes. Sci Rep 7(1):8822PubMedPubMedCentralCrossRef

35.

Facchini F, Chen YD, Hollenbeck CB, Reaven GM (1991) Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 266(21):3008–3011PubMedCrossRef

36.

Seyed-Sadjadi N, Berg J, Bilgin AA, Grant R (2017) Visceral fat mass: is it the link between uric acid and diabetes risk? Lipids Health Dis 16(1):142PubMedPubMedCentralCrossRef

37.

Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J (2000) Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 59(7):539–543PubMedPubMedCentralCrossRef

38.

Fan J, Xu JH, Wang J, Wang GZ, Zhang YQ, Liu XZ (2014) Effects of laparoscopic adjustable gastric banding on weight loss, metabolism, and obesity-related comorbidities: 5-year results in China. Obes Surg 24(6):891–896PubMedCrossRef

39.

Richette P, Doherty M, Pascual E, Barskova V, Becce F et al (2017) Castañeda-Sanabria J, 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 76(1):29–42PubMedCrossRef

40.

Dalbeth N, Bardin T, Doherty M, Lioté F, Richette P, Saag KG et al (2017) Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN). Nat Rev Rheumatol 13(9):561–568PubMedCrossRef

41.

Nielsen SM, Bartels EM, Henriksen M, Wæhrens EE, Gudbergsen H, Bliddal H et al (2017) Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies. Ann Rheum Dis 76(11):1870–1882PubMedPubMedCentralCrossRef

42.

Deurenberg P, Deurenberg-Yap M, Guricci S (2002) Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev 3(3):141–146PubMedCrossRef

Titel: Association between hyperuricemia and nontraditional adiposity indices
verfasst von: Xing Zhen Liu
Hui Hua Li
Shan Huang
Dong Bao Zhao
Publikationsdatum: 29.11.2018
Verlag: Springer London
Erschienen in: Clinical Rheumatology / Ausgabe 4/2019
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-018-4374-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Association between hyperuricemia and nontraditional adiposity indices

Abstract

Background

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Low-dose rituximab as induction therapy for ANCA-associated vasculitis

Comparison Between INSPIRE and Domjan method for measuring lumbar lateral flexion in patients of psoriatic arthritis (PsA) and correlation with radiographic damage

Efficacy of ω-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials

A TRAF6 genetic variant is associated with low bone mineral density in rheumatoid arthritis

The gait deviations of ankylosing spondylitis with hip involvement

Frequency and spectrum of outpatient musculoskeletal diagnoses at a pediatric hospital in Kenya

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin